Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effect of intraocular pressure control on visual field progression in the HORIZON trial.

Ophthalmology. Glaucoma·2026

Same author

Evaluation of the Deep Reality Viewer for teaching slit-lamp examination of the anterior segment and the optic nerve head.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2026

Same author

Comparative Outcomes of Standalone Xen63 Gel Stent and Preserflo Microshunt Implantation: A Multicenter Study.

Clinical ophthalmology (Auckland, N.Z.)·2026

Same author

The Flip Sides of Interventional Glaucoma.

Ophthalmology. Glaucoma·2026

Same author

Structure-Function Correlation of Virtual Reality and Standard Perimetry With Peripapillary RNFL OCT in Glaucoma Patients.

Translational vision science & technology·2026

Same author

Follow-up after cataract surgery: a cross-sectional survey of Canadian practice patterns at a large surgical centre.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2026

Same journal

Aflibercept 24-Month Outcomes in Diabetic Macular Edema With and Without Prior Macular Laser Therapy: Data from the Fight Retinal Blindness! Registry.

Ophthalmology and therapy·2026

Same journal

Experiences and Perspectives on Diabetic Retinopathy Screening and Treatment in Mexico: A Subanalysis of the Diabetic Retinopathy Barometer Study.

Ophthalmology and therapy·2026

Same journal

Intraoperative Modified Peripheral Panretinal Photocoagulation in Proliferative Diabetic Retinopathy.

Ophthalmology and therapy·2026

Same journal

Topical Insulin for Corneal Persistent Epithelial Defects: A Multicenter Retrospective Study.

Ophthalmology and therapy·2026

Same journal

Identification of OCTA Biomarkers and Cutoff Values Associated with Disease Severity in Dry Age-Related Macular Degeneration.

Ophthalmology and therapy·2026

Same journal

Advances in Polypoidal Choroidal Vasculopathy (PCV) Management: Emerging Evidence for Faricimab and Aflibercept 8 mg.

Ophthalmology and therapy·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 19, 2025

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

New Devices in Glaucoma.

Lilian Chan¹, Marlene R Moster², Amanda K Bicket³

¹Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, 51 North 39th St., Philadelphia, PA, 19104, USA.

Ophthalmology and Therapy

|August 9, 2023

Summary

This summary is machine-generated.

Novel minimally invasive glaucoma devices offer new therapeutic options for vision preservation. Further research is needed to confirm their long-term effectiveness in managing glaucoma.

Keywords:

Delayed-action preparation Excimer laser trabeculostomy Glaucoma Glaucoma drainage implants MINIject Minimally invasive glaucoma surgery Minimally invasive micro sclerostomy Multi-pressure dial Visiplate iDOSE

More Related Videos

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

Related Experiment Videos

Last Updated: Jul 19, 2025

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

Area of Science:

Ophthalmology
Medical Devices
Glaucoma Research

Background:

Glaucoma is a primary cause of global blindness.
Traditional treatments are expanding with minimally invasive techniques.

Purpose of the Study:

To review novel devices for glaucoma management.
To discuss emerging therapeutic options.

Main Methods:

Literature review of new and developing glaucoma devices.
Categorization of devices by mechanism of action (e.g., enhancing outflow, drug delivery).

Main Results:

Overview of devices targeting subconjunctival, Schlemm's canal, and suprachoroidal spaces.
Inclusion of sustained-release drug delivery and novel extraocular devices.
Identification of devices newly available or in development.

Conclusions:

Minimally invasive devices represent a growing field in glaucoma treatment.
Long-term efficacy and integration into clinical practice require further investigation.